Here today - Not gone tomorrow: Roles for activating receptors in sustaining NK cells during viral infections

European Journal of Immunology

Volumn 40, Issue 4, 2010, Pages 923-932

  Lee, Seung Hwan ^a   Biron, Christine A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Activating receptors; NK cells; Proliferation; Viral infections

Indexed keywords

CYTOKINE; NATURAL KILLER CELL RECEPTOR;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; CELL KILLING; CELL LOSS; CELL PROLIFERATION; CYTOKINE PRODUCTION; HOMEOSTASIS; HUMAN; IMMUNOPATHOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL; CELL DIVISION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HAPLORHINI; HUMANS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MICE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, NATURAL KILLER CELL; VIRUS DISEASES;

EID: 77951053764     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040304     Document Type: Review

References (72)

1. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. and Salazar-Mather, T. P., Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999. 17: 189-220.
2. Lee, S. H., Miyagi, T. and Biron, C. A., Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 2007. 28: 252-259. (Pubitemid 46810349)
3. Biron, C. A., Byron, K. S. and Sullivan, J. L., Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989. 320: 1731-1735.
4. Yokoyama,W. M. and Plougastel, B. F., Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 2003. 3: 304-316.
5. Lanier, L. L., Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008. 9: 495-502.
6. Caligiuri, M. A., Human natural killer cells. Blood 2008. 112: 461-469.
7. Hayakawa, Y., Huntington, N. D., Nutt, S. L. and Smyth, M. J., Functional subsets of mouse natural killer cells. Immunol. Rev. 2006. 214: 47-55.
8. Orange, J. S., Wang, B., Terhorst, C. and Biron, C. A., Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 1995. 182: 1045-1056.
9. Orange, J. S. and Biron, C. A., An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 1996. 156: 1138-1142.
10. Orange, J. S. and Biron, C. A., Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 1996. 156: 4746-4756.
11. Nguyen, K. B., Salazar-Mather, T. P., Dalod, M. Y., Van Deusen, J. B., Wei, X. Q., Liew, F. Y., Caligiuri, M. A. et al., Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 2002. 169: 4279-4287.
12. Dokun, A. O., Kim, S., Smith, H. R., Kang, H. S., Chu, D. T. and Yokoyama, W. M., Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001. 2: 951-956.
13. Lee, S. H., Kim, K. S., Fodil-Cornu, N., Vidal, S. M. and Biron, C. A., Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J. Exp. Med. 2009. 206: 2235-2251.
14. Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., Streeck, H. et al., Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 2007. 204: 3027-3036.
15. + NK cells during acute human immunodeficiency virus type 1 infection. J. Virol. 2009. 83: 6798-6805.
16. De Maria, A., Fogli, M., Mazza, S., Basso, M., Picciotto, A., Costa, P., Congia, S. et al., Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 2007. 37: 445-455.
17. Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N. and Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 3664-3671. (Pubitemid 39564443)
18. Williams, H., McAulay, K., Macsween, K. F., Gallacher, N. J., Higgins, C. D., Harrison, N., Swerdlow, A. J. et al., The immune response to primary EBV infection: a role for natural killer cells. Br. J. Haematol. 2005. 129: 266-274.
19. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. and Lanier, L. L., Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002. 296: 1323-1326. (Pubitemid 34522789)
20. Smith, H. R., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K. et al., Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 2002. 99: 8826-8831.
21. Bubic, I., Wagner, M., Krmpotic, A., Saulig, T., Kim, S., Yokoyama, W. M., Jonjic, S. et al., Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 2004. 78: 7536-7544. (Pubitemid 38915900)
22. Fodil-Cornu, N., Lee, S. H., Belanger, S., Makrigiannis, A. P., Biron, C. A., Buller, R. M. and Vidal, S. M., Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J. Immunol. 2008. 181: 6394-6405.
23. Tarazona, R., Casado, J. G., Delarosa, O., Torre-Cisneros, J., Villanueva, J. L., Sanchez, B., Galiani, M. D. et al., Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J. Clin. Immunol. 2002. 22: 176-183.
24. + cell counts in treated HIV-1-infected children. J. Infect. Dis. 2005. 191: 1451-1459.
25. Meier, U. C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., Tang, K. et al., Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J. Virol. 2005. 79: 12365-12374. (Pubitemid 41346098)
26. + NK cells. J. Virol. 2010. 84: 1183-1188.
27. Morishima, C., Paschal, D. M., Wang, C. C., Yoshihara, C. S., Wood, B. L., Yeo, A. E., Emerson, S. S. et al., Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 2006. 43: 573-580.
28. Golden-Mason, L., Madrigal-Estebas, L., McGrath,E., Conroy, M. J., Ryan, E. J., Hegarty, J. E., O'Farrelly, C. et al., Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 2008. 57: 1121-1128.
29. + cells in life-threatening varicella. J. Infect. Dis. 2005. 191: 198-206.
30. Reed, D. S., Hensley, L. E., Geisbert, J. B., Jahrling, P. B. and Geisbert, T.W., Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. Viral Immunol. 2004. 17: 390-400.
31. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M. et al., Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001. 409: 1055-1060. (Pubitemid 32204059)
32. Dunn, C., Chalupny, N. J., Sutherland, C. L., Dosch, S., Sivakumar, P. V., Johnson, D. C. and Cosman, D., Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 2003. 197: 1427-1439.
33. Fuller,C. L., Ruthel, G.,Warfield, K. L., Swenson, D. L., Bosio, C. M., Aman, M. J. and Bavari, S., NKp30-dependent cytolysis of filovirus-infected human dendritic cells. Cell. Microbiol. 2007. 9: 962-976.
34. Chisholm, S. E., Howard, K., Gomez, M. V. and Reyburn, H. T., Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors. J. Infect. Dis. 2007. 195: 1160-1168.
35. Stewart, C. A., Laugier-Anfossi, F., Vely, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L. et al., Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA 2005. 102: 13224-13229.
36. Chisholm, S. E. and Reyburn, H. T., Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J. Virol. 2006. 80: 2225-2233.
37. Gazit, R., Gruda, R., Elboim, M., Arnon, T. I., Katz, G., Achdout, H., Hanna, J. et al., Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006. 7: 517-523.
38. Kielczewska, A., Pyzik, M., Sun, T., Krmpotic, A., Lodoen, M. B., Munks, M.W., Babic, M. et al., Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 2009. 206: 515-523.
39. + T cells and NK cells in vivo. Nat. Immunol. 2002. 3: 529-535.
40. Lodoen, M., Ogasawara, K., Hamerman, J. A., Arase, H., Houchins, J. P., Mocarski, E. S. and Lanier, L. L., NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 2003. 197: 1245-1253.
41. Choi, E. I., Reimann, K. A. and Letvin, N. L., In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys. J. Virol. 2008. 82: 6758-6761.
42. Bukowski, J. F., Woda, B. A., Habu, S., Okumura, K. and Welsh, R. M., Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 1983. 131: 1531-1538. (Pubitemid 13048919)
43. Usherwood, E. J., Meadows, S. K., Crist, S. G., Bellfy, S. C. and Sentman, C. L., Control of murine gammaherpesvirus infection is independent of NK cells. Eur. J. Immunol. 2005. 35: 2956-2961.
44. Carlyle, J. R., Mesci, A., Fine, J. H., Chen, P., Belanger, S., Tai, L. H. and Makrigiannis, A. P., Evolution of the Ly49 and Nkrp1 recognition systems. Semin. Immunol. 2008. 20: 321-330.
45. Kulkarni, S., Martin, M. P. and Carrington, M., The Yin and Yang of HLA and KIR in human disease. Semin. Immunol. 2008. 20: 343-352.
46. MacFarlane, A. W. T. and Campbell, K. S., Signal transduction in natural killer cells. Curr. Top. Microbiol. Immunol. 2006. 298: 23-57.
47. Biron, C. A. and Sen, G. C., Innate immune responses to viral infection. in: Knipe, D. M. and Howley, P. M. (Eds.), Fields Virology, 5th Edn, Lippincott Williams & Wilkins, Philadelphia 2007, pp. 249-278.
48. Raulet, D. H., Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003. 3: 781-790.
49. Schepis, D., D'Amato, M., Studahl, M., Bergstrom, T., Karre, K. and Berg, L., Herpes simplex virus infection downmodulates NKG2D ligand expression. Scand. J. Immunol. 2009. 69: 429-436.
50. Salazar-Mather, T. P., Hamilton, T. A. and Biron, C. A., A chemokine-to-cytokine- to-chemokine cascade critical in antiviral defense. J. Clin. Invest. 2000. 105: 985-993.
51. Schoenborn, J. R. andWilson, C. B., Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007. 96: 41-101.
52. Krebs, P., Barnes, M. J., Lampe, K., Whitley, K., Bahjat, K. S., Beutler, B., Janssen, E. et al., NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood 2009. 113: 6593-6602.
53. Brady, J., Hayakawa, Y., Smyth, M. J. and Nutt, S. L., IL-21 induces the functional maturation of murine NK cells. J. Immunol. 2004. 172: 2048-2058. (Pubitemid 38182350)
54. Maroof, A., Beattie, L., Zubairi, S., Svensson, M., Stager, S. and Kaye, P. M., Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity 2008. 29: 295-305.
55. Deniz, G., Erten, G., Kucuksezer, U. C., Kocacik, D., Karagiannidis, C., Aktas, E., Akdis, C. A. et al., Regulatory NK cells suppress antigen-specific T cell responses. J. Immunol. 2008. 180: 850-857.
56. Brockman, M. A., Kwon, D. S., Tighe, D. P., Pavlik, D. F., Rosato, P. C., Sela, J., Porichis, F. et al., IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009. 114: 346-356.
57. Biron, C. A., Su, H. C. and Orange, J. S., Function and regulation of natural killer (NK) cells during viral infections: characterization of responses in vivo. Methods 1996. 9: 379-393.
58. Nguyen, K. B., Cousens, L. P., Doughty, L. A., Pien, G. C., Durbin, J. E. and Biron, C. A., Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat. Immunol. 2000. 1: 70-76.
59. Miyagi, T., Gil, M. P., Wang, X., Louten, J., Chu, W. M. and Biron, C. A., High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J. Exp. Med. 2007. 204: 2383-2396.
60. Biron, C. A. and Welsh, R. M., Blastogenesis of natural killer cells during viral infection in vivo. J. Immunol. 1982. 129: 2788-2795. (Pubitemid 13245561)
61. Biron, C. A., Young, H. A. and Kasaian, M. T., Interleukin 2-induced proliferation of murine natural killer cells in vivo. J. Exp. Med. 1990. 171: 173-188.
62. Biron, C. A. and Orange, J. S., IL12 in acute viral infectious disease. Res. Immunol. 1995. 146: 590-600.
63. French, A. R., Sjolin, H., Kim, S., Koka, R., Yang, L., Young, D. A., Cerboni, C. et al., DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J. Immunol. 2006. 177: 4981-4990. (Pubitemid 44527567)
64. Sun, J. C., Beilke, J. N. and Lanier, L. L., Adaptive immune features of natural killer cells. Nature 2009. 457: 557-561.
65. Sun, J. C., Ma, A. and Lanier, L. L., Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection. J. Immunol. 2009. 183: 2911-2914.
66. Geurs, T. L., Zhao, Y. M., Hill, E. B. and French, A. R., Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation duringmurine cytomegalovirus infection. J. Immunol. 2009. 183: 5830-5836.
67. Alter, G., Suscovich, T. J., Kleyman, M., Teigen, N., Streeck, H., Zaman, M. T., Meier, A. et al., Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection. AIDS 2006. 20: 1549-1551. (Pubitemid 44100216)
68. Alter, G., Teigen, N., Ahern, R., Streeck, H., Meier, A., Rosenberg, E. S. and Altfeld,M., Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J. Infect. Dis. 2007. 195: 1452-1460.
69. + T cells and interferon gamma are essential for the disorder. Blood 2004. 104: 735-743.
70. + Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009. 31: 772-786.
71. Wesley, J. D., Tessmer, M. S., Chaukos, D. and Brossay, L., NK cell-like behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathog. 2008. 4: e1000106.
72. Ahmed, R. and Gray, D., Immunological memory and protective immunity: understanding their relation. Science 1996. 272: 54-60. (Pubitemid 26110754)